Modern Biosciences is a drug development company that sources late-stage discovery projects from academia and spin-out companies, conducts early proof-of-principle clinical studies and subsequently out-licenses the resulting programs to the pharmaceutical and biotechnology industries.
View Top Employees from Modern BiosciencesWebsite | http://www.modernbiosciences.com |
Revenue | $7 million |
Employees | View employees |
Founded | 2006 |
Address | 24 Cornhill, London, Greater London EC4N 6NP, GB |
Industry | Pharmaceuticals, Healthcare, Biotechnology, Drug Manufacturing & Research |
Competitors | Auris Medical Holding AG, Evotec, Magen BioSciences |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Modern Biosciences employee's phone or email?
The Modern Biosciences annual revenue was $7 million in 2023.
Modern Biosciences is based in London, Greater London.
The NAICS codes for Modern Biosciences are [32, 3254, 32541, 325].
The SIC codes for Modern Biosciences are [283, 28, 2834].